Trials / Conditions / Neuroendocrine Tumor Grade 1
Neuroendocrine Tumor Grade 1
7 registered clinical trials studyying Neuroendocrine Tumor Grade 1 — 5 currently recruiting.
| Status | Trial | Sponsor | Phase |
|---|---|---|---|
| Recruiting | Absorbed Tumor Dose in Peptide Receptor Radionuclide Therapy with Long-acting Somatostatin Analogues - ATSA Tr NCT06855095 | The Netherlands Cancer Institute | Phase 2 / Phase 3 |
| Recruiting | 177Lu-DOTATATE Modified Delivery Based on Individualized Dosimetry NCT06395402 | University of Iowa | Phase 2 |
| Recruiting | Everolimus 5 mg vs 10 mg/Daily for Patients With Neuroendocrine Tumors NCT06472388 | AC Camargo Cancer Center | Phase 2 |
| Active Not Recruiting | A Safety Study of 212Pb-VMT-alpha-NET in Patients With Neuroendocrine Tumors NCT06148636 | David Bushnell | EARLY_Phase 1 |
| Active Not Recruiting | A First-in-human Clinical Trial to Evaluate an Alpha-radiation Imaging Agent NCT05111509 | Yusuf Menda | EARLY_Phase 1 |
| Recruiting | Pancreatic Radiofrequency Under High Echo-endoscopy in the Management of Pancreatic Neuroendocrine Tumors NCT04520932 | Institut Paoli-Calmettes | N/A |
| Recruiting | Rediscovering Biomarkers for the Diagnosis and Early Treatment Response in NEN (REBORN) NCT04464122 | University of Roma La Sapienza | — |